Journals / Türk Biyokimya Dergisi / 2017 / Cilt: 42 - Sayı: 2

Is there a relation between Murine double minute 2 T309G polymorphism and lung cancer risk in the Turkish population?

Türk populasyonunda Murine double minute 2 polimorfizmi ve akciğer kanseri riski arasında bir ilişki var mı?

Pages
123–129
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: No correlation between Murine double minute 2 T309G polymorphism and lung cancer risk was detected in this Turkish population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Association between Murine double minute 2 T309G polymorphism and lung cancer risk has been investigated in several populations, but results of these studies are inconsistent.
📊
Key Findings & Data:We aimed to investigate the effect of Murine double minute 2 T309G polymorphism on development of lung cancer in a Turkish population.Methods: Total 200 subjects including 100 patients and 100 controls were analyzed and used polymerase chain reaction and restriction fragment length polymorphism methods for genotyping analysis of the polymorphism.Results: We found that smokers compared with nonsmokers have approximately eight fold higher lung cancer risk [p = 0.0001, OR = 8.27 (4.02–16.9)].
💡
Conclusion & Impact:Conclusion: No correlation between Murine double minute 2 T309G polymorphism and lung cancer risk was detected in this Turkish population.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Association between Murine double minute 2 T309G polymorphism and lung cancer risk has been investigated in several populations, but results of these studies are inconsistent. We aimed to investigate the effect of Murine double minute 2 T309G polymorphism on development of lung cancer in a Turkish population.Methods: Total 200 subjects including 100 patients and 100 controls were analyzed and used polymerase chain reaction and restriction fragment length polymorphism methods for genotyping analysis of the polymorphism.Results: We found that smokers compared with nonsmokers have approximately eight fold higher lung cancer risk [p = 0.0001, OR = 8.27 (4.02–16.9)]. Frequency of GG genotype was higher in patients than in controls, but this ratio was not significant (χ2 = 3.5, p = 0.17). Genotype distribution of the polymorphism was not different neither patients with non-small cell lung cancer nor patients with small cell lung cancer (χ2 = 2.89, p = 0.57). We analyzed together with demographic feature (except smoking habit), clinicopathological findings and genotype frequencies of this polymorphism, and any association with lung cancer risk was not obtained. Conclusion: No correlation between Murine double minute 2 T309G polymorphism and lung cancer risk was detected in this Turkish population.

Özet

Giriş: Çeşitli popülasyonlarda akciğer kanseri riski ile Murine double minute 2 T309G polimorfizminin birlikteliği incelenmiş, fakat bu çalışmaların sonuçları arasında tutarsızlık olduğu görülmüştür. Bu çalışmada, bir Türk popülasyonunda akciğer kanserinin gelişimi üzerine Murine double minute 2 polimorfizminin etkisini araştırmayı amaçlanmıştır.Yöntemler: Bu çalışmada, 100 hasta 100 kontrolden oluşan toplam 200 örnek incelenmiş ve bu polimorfizmin genotip analizi için polimeraz zincir reaksiyonu ve restriksiyon fragment uzunluk polimorfizmi yöntemleri kullanılmıştır.Bulgular: Çalışmada sigara içmeyenlerle karşılaştırıldığında sigara içenlerin yaklaşık olarak sekiz kat daha fazla akciğer kanseri gelişme riskine sahip oldukları bulunmuştur [p = 0.0001, OR = 8.27 (4.02-16.9)]. GG genotipi kontrollere oranla hastalar arasında daha yüksek oranda bulunmuştur fakat bu oran anlamlı değildir (?2 = 3.5, p = 0.17). Bu polimorfizmin genotip dağılımı ne küçük hücreli akciğer kanseri olan hastalarda ne de küçük hücreli olmayan akciğer kanseri olan hastalarda farklılık göstermediği bulunmuştur (?2 = 2.89, p = 0.57). Polimorfizmin genotip sıklıkları, klinikopatolojik bulgular ve demografik özellikler (sigara alışkanlığı hariç) birlikte değerlendirilmiş ve bu bulgular arasında akciğer kanseri riski ile herhangi bir ilişki elde edilememiştir.Sonuç: Bu Türk popülasyonunda akciğer kanseri riski ve Murine double minute 2 T309G polimorfizmi arasında bir korelasyon belirlenememiştir

🔖

Cite This Article

SARİ, M., SİLİG, Y., KACAN, T., YİLMAZ, M., TAS, A. (2022). Is there a relation between Murine double minute 2 T309G polymorphism and lung cancer risk in the Turkish population?. Türk Biyokimya Dergisi, Cilt: 42 - Sayı: 2, 123–129. https://ajindex.com/articles/621328

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Lyon, France: International Agency for Research on Cancer, 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No
  2. Available at: http://globocan.iarc.fr. Accessed: 21 Jan 2014
  3. Başara BB, Güler C, Yentür GK, Birge B, Pulgat E, Ekinci BM. T.C. Saglik Bakanligi Sağlik Istatistikleri Yilligi 2012, ISBN: 978-975- 590-471-9, Sağlık Bakanlığı Yayın No: 917, Sağlık Araştırmaları Genel Müdürlüğü Yayın No: SB-SAG-2013/01, Baskı: Sentez Matbaacılık ve Yayıncılık İstanbul Cad. İstanbul Çarşısı No: 48/10 İskitler/ANKARA
  4. Cooper WA, Lam DC, O’Toole SA, Minna JD. Molecular biology of lung cancer. J Thorac Dis 2013;5:S479–90
  5. Ryan BM, Calhoun KM, Pine SR, Bowman ED, Robles AI, Ambs S, et al. MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. Int J Cancer 2012;131:2710–6
  6. Zhao E, Cui D, Yuan L, Lu W. MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis. Mol Biol Rep 2012;39:3471–7
  7. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 2004;119:591–602
  8. Chen W, Wu Q, Ren H. Meta-analysis of associations between MDM2 SNP309 polymorphism and gastric cancer risk. Biomed Rep 2014;2:105–11
  9. Akkiz H, Sümbül AT, Bayram S, Bekar A, Akgöllü E. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. Cancer Epidemiol 2010;34:448–52
  10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
  11. Hu Z, Ma H, Lu D, Qian J, Zhou J, Chen Y, et al. Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population. Int J Cancer 2006;118:1275–8
  12. Pine SR, Mechanic LE, Bowman ED, Welsh JA, Chanock SC, Shields PG, et al. MDM2 SNP309 and SNP354 are not associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:1559–61
  13. Zhang X, Miao X, Guo Y, Tan W, Zhou Y, Sun T, et al. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Hum Mutat 2006;27:110–7
  14. Park SH, Choi JE, Kim EJ, Jang JS, Han HS, Lee WK, et al. MDM2 309T>G polymorphism and risk of lung cancer in a Korean population. Lung Cancer 2006;54:19–24
  15. Lind H, Zienoldd